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Each year there are over 1.7 million traumatic brain injuries (TBI) in the United States 
causing long-term health deficits and significant medical costs.  This growing epidemic 
has led researchers to find methods for treating and preventing these injuries.  
Environmental Enrichment (EE) is an innovative technique shown to improve cognitive 
and functional outcomes following a TBI; however, the beneficial effects before injury 
have not been established.  Brain-Derived Neurotrophic Factor (BDNF) has been 
determined as a neuroprotective biomolecule in TBI.  This research examined these two 
protective components and their roles in TBI.  It was hypothesized that BDNF mRNA 
and protein levels would be elevated in animals environmentally enriched prior to TBI 
compared to non-enriched animals.  Results indicated that EE applied before TBI 
improved cognitive performance, but BDNF mRNA and protein levels were not elevated 
significantly. These findings require further examination to determine a more definitive 
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Traumatic Brain Injury 
The Center for Disease Control and Prevention has reported that each year 
approximately 1.7 million people sustain a Traumatic Brain Injury (TBI), leading to long-
term health deficits as well as significant direct and indirect medical costs
1
.  Of these 1.7 
million injuries, nearly 50,000 patients die and 90,000 individuals experience permanent 
disability
2
.  According to the World Health Organization, TBI will surpass many diseases 
as the major cause of death and disability by the year 2020, with an estimated 10 million 
people affected annually2.  In 2000, the cost of direct and indirect care for patients 
suffering from a TBI accounted for nearly 60 billion dollars
 
in the United States alone
1
.  
Traumatic Brain Injury is a costly, devastating condition which can generate long-lasting 
social and occupational disabilities in behavior, memory, and executive function, and the 
need for preventative measures against this epidemic are crucial
3
. 
TBI is commonly categorized into three levels of severity.  These levels include 
mild, moderate, and severe TBI.  Studies using rodents have determined that the severity 
of a TBI directly correlates with the amount of histological manipulation, locomotor and 
cognitive deficits seen post-injury
4,5
.  Consequently, as TBI severity is increased, damage 
to the central nervous system (CNS) tends to extend beyond the initial site of injury and 
spread to other regions of the brain, particularly the hippocampus
4,5
.  This structure is 
considered part of the limbic system and is located in the basal medial part of the 
temporal lobe
6
.  The hippocampus is configured in a curved formation and is composed 
of various layers of neurons
6
.  Functions of the hippocampus include learning, memory 
and integration of information.
 
 Following a TBI, these functions have been shown to be 
disrupted
7
.  Although the hippocampus may not be impacted directly during the injury, 
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the processes which occur after a TBI may result in deleterious effects on this vital brain 
component. 
Mechanisms of TBI 
There are three main stages (acute, sub-acute & chronic) which occur following a 
TBI.  The first stage (acute) occurs at or near the site of injury and results in direct tissue 
damage, impaired regulation of cellular metabolism, penetration of the blood brain 
barrier and cellular death
8,9
.  This stage can only be treated by preventative measures 
prior to the injury, not therapeutic treatments after the TBI
8
.  The second stage (sub-
acute) is characterized by membrane depolarization which leads to the excessive release 
of excitotoxic neurotransmitters, such as glutamate, and cytokines
8
.  These biomolecules 
act on the brain to induce cell necrosis and heighten the initial damage.  The third stage 
(chronic) following a TBI is delayed cell death which is caused by apoptotic influences 
such as inflammation
9
.  Each stage plays a vital role in the outcome of patients suffering 
the deleterious effects of a TBI (Figure 1).   
During the acute stage, direct tissue damage may occur depending on the severity 
of the TBI
8
.  This trauma can cause cellular necrosis at the site of injury and activate the 
hypothalamic-pituitary-adrenal axis (HPA axis).  The TBI can also disrupt the integrity of 
the blood brain barrier and impair cellular metabolism
8,10
.  Necrosis causes the release of 
excitatory neurotransmitters and induces cellular metabolic failure
8
.  This metabolic 
failure causes a loss of adenosine triphosphate (ATP) production, initiating energy-
dependent ion pump malfunction and leading to detrimental effects on the cells of the 
brain
8




Figure 1: Mechanistic effects of a traumatic brain injury distinguished by stages.  
During the acute stage, numerous physical and biochemical disruptions occur which 
can lead to neuronal degeneration.  These effects have the ability to carry over into the 
sub-acute stage which increases degeneration by increasing apoptosis.  The chronic 
stage includes inflammation and advanced apoptosis, causing detrimental effects to the 
CNS.    
 
Once the HPA axis is activated, corticotrophin-releasing hormone (CRH) and arginine 
vasopressin (AVP) are released from the paraventricular nucleus of the hypothalamus
5,10
.  
The expression of these hormones causes the release of adrenocorticotrophic hormone 
(ACTH) from the pituitary, and in turn, ACTH stimulates the biosynthesis and release of 
glucocorticoids (GCs), such as cortisol, from the adrenal cortex
10




Figure 2: Normal HPA Axis Response to Stress.  Once a stress transpires, the 
hypothalamus and PVN activate and release CRH and AVP.  These hormones activate 
the anterior pituitary which leads to the release of ACTH.  Discharging that hormone 
causes the adrenal cortex to expel cortisol.  The adrenal cortex has a negative feedback 
loop to both the hypothalamus and anterior pituitary which aids in the regulation of the 
system, and assists in regaining homeostasis.   
 
Under normal conditions, these GCs act under a feedback loop with the hypothalamus to 
reduce the amount of CRH produced and prevent over-activation of the system
11
.  
Following a TBI, there is dysregulation of the HPA axis, providing persistent exposure to 
GCs and numerous detrimental effects throughout the CNS
10-12
.    
The sub-acute stage occurs hours to days following injury.  During this stage, 
neurons near the site of injury swell, shrink and eventually die, resulting in neuronal 
degeneration
8,9
.  This stage is characterized by the excessive release of excitotoxic 
neurotransmitters, increased lesion size and number of neuronal apoptotic cells and the 
activation of voltage-dependent ion channels
8,11
.  Fluxes in ionic concentrations cause 
calcium (Ca
2+
) and sodium (Na
+
) imbalances which can result in detrimental effects 
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throughout the brain.  These effects may include the release and upregulation of 
cytokines, further blood brain barrier breakdown and the need for more energy to 
compensate for the dysfunction of the ionic gradients
8,11,13
.   
The chronic stage of a TBI includes delayed cell death due to processes such as 
inflammation and can occur instantaneously through weeks following insult
14
.  This 
inflammatory response involves the release of cytokines like tumor necrosis factor-α 
(TNF-α), interleukin-4 and interleukin-1beta (IL-1β).  These cytokines produce positive 
effects including the elimination of injured and adjacent tissue as well as negative effects 
like increases in apoptotic neurons in the cortex and hippocampus, activation and 
accumulation of immune cells such as lymphocytes and leukocytes and impaired 
neuronal function
8,10,13
.  Studies have shown that neuronal reduction and dystrophy due to 
the accumulation of immune cells may account for the long-term deficits which occur 
after a TBI
14-16
.  These effects highlight that the inflammatory process is a balance 
between the cytokines which play important regulatory functions during a TBI.  If this 
balance becomes disrupted, detrimental effects may occur which could lead to vast 
cognitive and physical deficits
14
.  During this stage, the subfields of the hippocampus 
have also demonstrated upregulation of dystrophic neurons due to inflammation, which 
can lead to cell death, providing evidence of the vulnerability of the hippocampus to the 
inflammatory process
17
.  The dentate gyrus (DG), CA1 and CA3 regions of the 
hippocampus are particularly sensitive to cognitive function and learning, and damage to 




Figure 3: Hippocampus Anatomy; Paxinos, (2007) The Rat Brain 
 
Biomolecules Involved in TBI 
Other biomolecules shown to be involved in the brain’s response to TBI are 
neurotrophic factors.  Neurotrophic factors are a unique family of growth factors which 
are locally produced in the nervous system and influence the survival, proliferation, 
differentiation and death of cells in the CNS
18
.  They are also able to mediate higher-
order activities such as learning, memory and behavior
18
.  There are numerous 
neurotrophins which have been distinguished and examples of these include: nerve 
growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) 
and neurotrophin-4 (NT-4).  Neurotrophic factors have the ability to influence the CNS in 
diverse ways based on their availability, their functionality once phosphorylated, their 
affinity to the appropriate receptors and the signaling cascades they stimulate
18
.  These 
factors have been shown to provide neuroprotective effects by influencing synaptic 
plasticity and neuronal function using cytokine pairing
16
.  Due to the fragility of this 
balance and the possibility of enhanced neuroprotective effects, many studies have been 
performed to determine ways which the levels of these growth factors may be regulated 
following injury.  One potential intervention that has been examined is environmental 
7 
 
enrichment (EE), which confers numerous positive effects following an insult, including 
changes in behavior and biochemical outcomes.              
Environmental Enrichment 
Environmental Enrichment was first established by Hebb et al. (1947) in the late 
1940’s.  It is a complex sensory-motor stimulation that provides animals with an 
increased opportunity for physical exercise, various learning experiences, and social 
interactions which may result in a variety of neuroplastic changes in the brain
19
.  In his 
experiments, Hebb found that early experiences and environments provide permanent 
effects on the problem-solving abilities of adult rats, and increasing task complexity led 
to better cognitive performance
19
.  Hebb attributed this phenomenon to neuronal 
plasticity, a term which refers to the brain transforming its elements or connectivity 
because of learning and cognitive function
19
.  This discovery led to a vast increase in 
experiments which have aided in the understanding of the connection between 
enrichment and plasticity.  Rosenzweig et al. (1996) determined that EE led to 
measurable changes in brain chemistry and weight
20
.  In his work, enriched rodents had 
increased cortical volume, most commonly due to the development of dendritic 
branching
20
.  Enriched housing also caused increased rates of messenger RNA (mRNA) 
and protein synthesis, which are required for long-term memories in various areas the 
brain
20,21
.  Following a brain insult, Rosenzweig also observed that EE improved motor 
skills and increased memory performance in rodent subjects
22
.  In a study by 
Kempermann et al. (1997), EE was found to produce a significant amount of new neurons 
and a larger granule cell layer in the hippocampus compared to standard housed 
animals
23
.  All of these positive effects collectively provided support for the idea that EE 
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When applied following TBI, EE facilitates learning and memory and improves 
motor skills performance
24,25
.  Models of injury include fluid percussion injury (FPI) and 
controlled cortical impact (CCI).  FPI induces an injury by rapidly injecting fluid 
volumes into the cranial cavity while CCI uses a pneumatic impactor to impact exposed 
brain
26,27
.   EE attenuates some of the detrimental effects that both FPI and CCI 
induce
26,27
.    Common trends of neuroprotection provided by enrichment after these 
injuries include; attenuation of hippocampal CA3 cell loss, reduction of overall lesion 
volume, induction of cell proliferation, reduction of inflammatory processes, production 
of growth factors and improved cognitive performance
28-30
.  Following an injury, rodents 
exposed to EE performed better on spatial memory tasks, including the Morris Water 
Maze (MWM), compared to their standard counterparts
24,30
.  Experiment models using 
rodents have also demonstrated attenuation of deficits following injury on the beam 
walking task (locomotor recovery assessment) and the sawdust maze (a test of learning) 
when EE was applied
22
.  EE is consequently able to influence not only the cellular 
processes when applied following injury, but also provide behavioral and physical task 
enhancements.   
The influence of environment on numerous biochemical and physical aspects 
following an injury may be modulated by transcription factor activation as well as growth 
factor expression
31
.  Transcription factors control and modulate the transcriptional 
activity of genes and respond to changes in brain dynamics, such as a TBI.  Growth 
factors generally act as signaling molecules between cells and once bound to their 
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specific receptors can initiate or inhibit cellular processes
32
.  During development, growth 
factors play a role in cell differentiation and neural outgrowth while in adulthood their 
function switches to tissue homeostasis and neurogenesis following injury
32
.  These 





Neurotrophins aid in the regulation and control of neuron development, function, 
survival and plasticity
33
.  Some of the responsibilities these regulators maintain include; 
control of cellular Ca
2+
 homeostasis, inhibition of programmed cell death, upregulation of 
enzymes for metabolism and amelioration of negative morphological and functional 
effects caused by brain injury
33
.  Neurotrophins are synthesized and packaged into 
vesicles in the soma, and are then transported to presynaptic axon terminals and released 
to postsynaptic dendrites by regulated or constitutive secretion
32
.  Most neurotrophins are 
released using the regulatory pathway and require a stimulus to induce their secretion
34
.  
Once these biomolecules are discharged, they autophosphorylate to induce functionality 
and activate signaling pathways throughout the CNS using either tropomyosin-related 
kinase (trk) receptors or a tumor necrosis family receptor, p75
NTR 33
.   
The trk receptors, part of the tyrosine kinase family, are found throughout the 
CNS.  Once stimulated, these receptors aid in the regulation of neuronal proliferation and 
survival, axonal and dendritic growth, synapse formation and function and repair of 
damaged neurons
33
. Tyrosine Receptor Kinase (trk) A is specific for NGF while trkB 
binds to both BDNF and NT-4.  Brain-derived neurotrophic factor can also bind with low 
affinity to the p75
NTR
 receptor, which may cause negative effects such as apoptosis and 
10 
 
long-term depression, as well as positive functions like signal transduction and cell 
survival
33
.           
Brain-Derived Neurotrophic Factor (BDNF) 
Each neurotrophin influences the brain following injury, including promotion of 
neuronal survival and plasticity of neuronal circuits, or neurotoxicity of the neurons from 
overexposure
34
.  One neurotrophin in particular, BDNF, is especially effective in 
promoting the survival of neurons following a TBI and is upregulated with the 
application of enrichment
35,36
.  These tendencies have led researchers to believe that 
BDNF may be an important neuroprotective component in the CNS. 
BDNF is a 27kDa activity-dependent modulator of neurogenesis, neuronal 
structure and function, synaptic plasticity and hippocampal function
37
.  BDNF is 
synthesized, stored and released from the glutamatergic neurons and distributed 
throughout the nerve terminals and dense-core vesicles
30,36,37
.  BDNF binds specifically 





BDNF is released following a stimulus, such as a TBI
36
.  Once released, BDNF 
can transport both anterogradely and retrogradely throughout the neurons
39
.  This bi-
directional movement of the neurotrophin allows for optimal exposure and binding with 
the trkB receptor
39
.  Binding of BDNF to its receptor activates the tyrosine kinase domain 
which can then stimulate various intracellular substrates
39
.  One of these substrates 
includes the lipid kinase phosphoinositide 3-kinase (PI3K), which upon activation 
localizes to the cell membrane
39,40
.  The PI3K pathway will cause phosphorylation of the 
survival serine/threonine protein kinase Akt by recruiting it to the membrane as well
40,41
.  
Once activated, Akt serves to phosphorylate multiple proteins and is a regulator of cell 
proliferation, glucose metabolism and cell survival
41
.  This mechanism (Figure 4) is a key 
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component and pathway for the beneficial effects that BDNF has on neuronal survival.  
BDNF, as well as the other neurotrophic factors, also have the capability to stimulate the 
activation of the mitogen-activated protein kinase (MAPK) pathway in hippocampal 
neurons
40
.  While this pathway is able to phosphorylate many of its downstream targets 
and produce an upregulation of BDNF mRNA, Zheng et al. (2004) were able to 
demonstrate that it was not as involved in the protective effects of BDNF compared to the 




Figure 4: BDNF Mechanism using PI3K Pathway.  BDNF causes the phosphorylation of 
its trkB receptor which causes the phosphorylation of PI3K.  The PI3K moves to the cell 
membrane and causes the phosphorylation of Akt.  Activation of Akt leads to cell survival 
and increased neurogenesis. 
 
Through the PI3K/Akt pathway, BDNF is able to induce multiple beneficial 
changes in the brain not only in the neurons, but also the synapses by being a mediator of 
synaptic transmission and plasticity
42
.  BDNF is involved both pre- and post-synaptically 
12 
 
and is consequently able to enhance synaptic transmission in the hippocampus by 
strengthening excitatory synapses, causing long term potentiation (LTP)
37,39
.  LTP is 
believed to be the mechanism behind learning and memory
37
.  The induction and 
maintenance of LTP is highly sustained by BDNF as shown by Bramham et al. (2005) 
when LTP was unable to be induced in BDNF knock-out mice
37
.  This study provides 
evidence of the crucial involvement of BDNF in processes involving synaptic plasticity
37
.      
BDNF is needed for neurogenesis, synaptic plasticity and hippocampal function
38
.  
Following a TBI, changes to the CNS may prohibit BDNF from completing these crucial 
tasks
26,43
.  Pro-inflammatory cytokines can inhibit the secretion of BDNF and certain 
physiological and psychological stressors have also reported decreasing the amount of 
BDNF protein found in the hippocampus
43
.  Reduction in BDNF under these conditions 
can result in a loss of synaptic activity and neuronal proliferation. 
Following a TBI, the levels of BDNF mRNA and protein in the neurons vary 
based on the effects of the injury on the hippocampus
26
.  Studies have shown that 
following a TBI, BDNF mRNA levels are increased contralateral to the injury for a short 
period (12-36 hours after injury) of time before returning to control levels whereas these 
levels are decreased significantly ipsilateral to the injury during this same time 
frame
26,27,43,44
.  These changes are seen most commonly in the CA3 and DG of the 
hippocampus
27
.  The DG granule cells show a more pronounced increase in BDNF levels 
and become selectively more resilient to cell death following injury
44
.  Increased BDNF 
in the CA3 region of the hippocampal pyramidal cells also correlated with an enhanced 
cell survival rate
44
.  These findings provide further evidence of the neuroprotective role 
13 
 
that BDNF plays following TBI in compensating for the loss of neurons and synapses in 
the hippocampus. 
Along with aiding in the recovery of hippocampal components, BDNF also plays 
a role in other functional areas.  When elevated, BDNF has been shown to enhance 
performance on the MWM task, illustrating the ability of this neurotrophic factor to 
positively influence cognitive performance
51
.  This research group also determined that 
changes induced by BDNF in synaptic plasticity, including enhanced connectivity 
throughout the brain, were associated with functional recovery following brain injury
51
.      
BDNF plays an important role in the recovery of function following a TBI, and 
when EE is applied the benefits of neuroprotection are increased
45,46
.  Enrichment alone 
enhances BDNF mRNA and protein levels in the rat hippocampus, cerebral cortex and 
hindbrain hours to days following application
45,47
.  By increasing these levels of BDNF, 
the amount of hippocampal neurons can elevate due to their improved survival tendencies 
and increased ability to differentiate
45,46
.  Both EE and BDNF play crucial roles in 
neuronal and synaptic survival and differentiation, and plasticity throughout the CNS.  By 
combining these components in an appropriate paradigm, the brain may be able to 
enhance its synaptic and neuronal connections, providing added neuroprotection against a 
TBI. 
Knowing the positive effects of both enrichment and BDNF following an injury 
has fueled research of how these components work together to provide cognitive 
enhancements if applied before injury.   The current research focuses on BDNF as a 
neuroprotective mechanism when paired with enrichment.  It is hypothesized that BDNF 
mRNA and protein levels will be elevated in animals which are enriched prior to TBI 
14 
 
compared to non-enriched animals.  Identifying the EE-induced mechanism behind 
























Materials & Methods 
Subjects 
Animals used in this study were male Sprague Dawley rats approximately 90 days 
of age from Charles River Laboratories.  Forty-two animals were used for behavioral 
testing while 21 were utilized for biochemical analysis.  Upon arrival, animals were 
separated into various housing conditions in a room with stable temperature  25 C) and a 
12 hour light/dark cycle.  The animals were provided ad libitum access to food and water 
and handled for 5 min/day or more depending on their housing condition.  Animals were 
weighed on a daily basis and were given 7 days to acclimate prior to testing.  These 
animals were part of a larger study which was focused on the effects of enrichment prior 
to TBI, and in that experimental design, behavioral testing was a focal point (Figure 5).     
 
 
Figure 5: Study Layout Timeline. Animals were housed appropriately 15 days prior to injury or 







Environmental enrichment rats were housed 8 per cage in a large wire mesh cage 
(~1m
3
) with a variety of items such as a running wheel, plastic tubes, ladders, ropes and 
mirrors (Figure 6) for 15 days before TBI.  Each day the toys were rearranged at feeding 
and twice weekly the items were replaced by new toys in order to provide the animals 
with novel stimuli.  Enriched animals also received acrobatic training (Figure 7) and were 
exposed to olfactory stimulation twice a day for 10 days (two 5-day blocks) following the 
acclimation period. 
 
Figure 6: Environmental Enrichment Cage.  Animals are socially housed and given 
novels toys to interact with.  Other stimulators include ropes, ladders, running wheel, 
olfactory stimulation and motor skills training 
 
 The EE cages were kept out of sight from the standard and control animal cages using 
wall dividers.  Enriched animals were subjected to a medial pre-frontal TBI following the 





Figure 7: Environmental Enrichment Acrobatic Training.  Animals are exposed to an 
obstacle course consisting of beams, ropes, and ladders which are elevated above the 
ground 
 
Standard and Control 
Standard (ST-TBI) and control (Sham) animals were housed 2 per standard 
polycarbonate shoebox cage for 15 days before TBI.  These animals did not receive 
contact with other animals or additional training and were handled with minimal contact 
(5min/day) during routine cage changing.  Standard animals were subjected to a medial 
pre-frontal TBI following the 15-days of standard housing.  The control group consisted 
of sham animals which underwent anesthesia and a craniotomy but did not receive an 
injury.   
Controlled Cortical Impact 
Enriched and ST-TBI animals were subjected to TBI via a controlled cortical 
impact (CCI) device following the 15 days of appropriate housing (Figure 5).  Animals 
were anesthetized with isoflurane (5% induction, 2% maintenance) and secured with their 
heads fixed in a horizontal position.  Blood saturation of peripheral oxygen (SpO2) and 
body temperature were closely monitored and maintained throughout the surgery.  A 
6mm craniotomy was performed 5mm anterior to bregma and the bone segment removed 
was discarded.  An electrical contusion impactor (Custom Design and Fabrication, 
Virginia Commonwealth University Medical Center, Richmond, Virginia) with a velocity 
of 2.25m/sec and a depth of 3mm was used to inflict the TBI at the prefrontal cortex 
18 
 
(total of 50msec of contact with the brain).  Following the procedure, the scalp was 
sutured with 7mm surgical staples.  Sham controls were anesthetized and received a 
craniotomy but not a CCI.  After surgery and recovery, animals were returned to their 
original cages and cage mates.  The EE group no longer received additional enrichment 
and the extra stimuli that had been dispersed in their cages were removed.  By 
discontinuing EE at this stage, data would reflect the effects of enrichment prior to injury 
only.   
 
Behavioral Testing 
All animals were subjected to behavioral testing starting 11 days post-injury 
(Figure 5).  The Morris Water Maze (MWM) was implemented to test spatial memory 
and learning.  Although other behavioral tests were performed, this paper will focus on 
the MWM because of its specificity in learning and memory which are correlated with 
hippocampal function as well as BDNF levels.      
 
Morris Water Maze 
The MWM was used 11 days after surgery to test spatial learning and memory.  
Animals were placed in a 70 inch diameter dark circular tank filled with water.  The tank 
was divided evenly into four quadrants (A, B, C, D) with appropriate marking of the 
quadrants on the top edge of the tank (Figure 8).  The platform consisted of 4 inch 
diameter clear plexiglass submerged 0.8 inches beneath the water level and placed 
approximately 11 inches from the wall of the pool in quadrant C.  Throughout the 




Figure 8: Morris Water Maze is a test of spatial learning and memory.  Animals are 
placed in a large pool and latency to find the hidden platform is recorded using 
Ethovision Software. 
 
Latency to find the hidden platform was recorded using Ethovision software (Noldus; 
Leesburg, VA).  The test was performed in two 5-day blocks over 10 days.  Each animal 
performed 2 trials per day, except for the 10
th
 day during which the platform was 
removed from the tank and animals were only tested once for the amount of time spent in 
quadrant C.  For each trial, the animal was placed in the pool in random quadrants, facing 
the wall.  If the animal was unable to locate the platform in 90 seconds, they were 
physically guided to it and upon reaching the platform were allowed to remain there for 
10 seconds.  They were then removed for a 30 second interval before the start of the 
second trial.     
Sacrifice 
Animals were sacrificed 33 days post-injury (Figure 5).  They were briefly 
anesthetized with 5% isoflurane until a toe pinching test received no reaction and 
decapitated via guillotine.  The brains were removed and split in half saggitally.  
Alternating left and right sides were kept intact and flash frozen in isopentane.  For in-
situ hybridization analysis, coronal sections of the brain hemispheres (14 µm) through the 
prefrontal cortex and hippocampus were cut on a cryostat and stored at -20˚C.  The 
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contralateral side was dissected to extract the hippocampus for Enzyme-Linked 
Immunosorbent Assay (ELISA) techniques and stored at -80˚C.   
Biochemical Analysis 
Protein quantification techniques were used to determine the amounts of BDNF 
and trkB mRNA and protein throughout various areas of the brain.  In-situ hybridization 
techniques were carried out at The University of Cincinnati under the supervision of Dr. 
Kim Seroogy while a Promega
®
 BDNF Immunoassay Kit was used to determine BDNF 
protein concentrations in the hippocampus. 
 
 In-Situ Hybridization 
Localization of BDNF and trkB mRNA was performed using in-situ hybridization 
as described by Hicks et al (1998)
48
.  Briefly, the unperfused slide-mounted sections were 
pretreated by removing the slides from the -20
ᵒ
C freezer and quickly drying them under a 
stream of cold air.  The slides were immersed in 4% paraformaldehyde for 10 minutes, 
washed twice for 5 min in 0.1M phosphate buffer saline (PBS), washed twice for 5 min in 
0.2% PBS/Glycine, washed again in 0.1M PBS, and then placed in 0.25% acetic 
anhydride/0.1M triethanolamine for 10 minutes.  The slides were then dehydrated using 
various concentrations of ethanol, delipidated in chloroform and air dried.  The BDNF 
and trkB cRNA probes (Kindly provided by Christine Gall, University of California-
Irvine and Kathryn Albers, University of Pittsburgh) were prepared using in vitro 
transcription from a linearized cDNA construct with T3 polymerase in the presence of 
35
S-UTP (NEG039H, Perkin Elmer). Hybridization was performed at 60˚C for 18-24 
hours using hybridization buffer [1M Tris-HCL + 0.5M EDTA + 50x Denhardt’s 
Solution + 5M NaCl + 10mg/mL denatured salmon sperm DNA + 15mg/mL yeast tRNA 




S-labeled cRNA probe].  Following hybridization 
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treatment, slides were washed with 4x saline-sodium citrate (SSC) + 10mM sodium 
thiosulfate at 37˚C twice for 30 minutes each, then incubated in ribonuclease A for 30 
minutes at 45˚C.  Slides were washed in 2X SSC and 0.5X SSC two times each at 37˚C 
for 20 minutes, and 0.1X SSC at 37˚C for 30 minutes.  Sections were dipped in dH2O 
followed by 95% EtOH, air-dried and loaded into cassettes with β-Max Hyperfilm 
(Amersham).  The films were exposed at room temperature for 10 days for BDNF and 7 
days for trkB in order to generate film autoradiograms.   Following film development, 
films were dipped in GPX developer and fixer (Kodak), air dried and then exposed in 
light-tight boxes at 4˚C for 2-4 weeks.  Upon completion of the autoradiographic 
development, slides were analyzed using a Nikon Optiphot-2 microscope and Scion 
software (NIH).  Analysis compared the density of hybridization for BDNF mRNA in the 
Piriform Cortex, Prefrontal Cingulate, DG and CA3 subfields.  Background hybridization 
from the proximal tissue was subtracted from the hybridization in the hippocampal 
subfields to obtain corrected optical density (OD) measurements.  Gray scale values were 
calculated by taking area of the region of interest into account as well.   
Hippocampal Preparations  
For immunoblot analysis of proteins, hippocampi (frozen at -80
ᵒ
C) were thawed 
on wet ice. During the thawing, 400µL of cold 0.3M sucrose buffer [102g sucrose + 4.3g 
Sodium Chloride + 1.21 g Tris Base + 40mL 500mM EDTA + 40mL 500mM EGTA] 
was placed in a 1.5mL microcentrifuge tube for each sample.  100µL of 0.2% Triton x-
100 (EW-88230-41; Cole-Parmer) and 4µL Protease Inhibitor (PI) Cocktail (P178415; 
VWR) were added to the sucrose buffer and mixed thoroughly.  The tissue sample was 
added to the appropriate microcentrifuge tube and minced using scissors for 
approximately 100 strokes.  The tube was placed back on wet ice for 10 minutes to allow 
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the PI to penetrate the sample fully. Following the incubation period, samples were 
homogenized using the Misonix S-4000
®
 sonicator (Fisher Scientific, Pittsburgh PA).  
Timed intervals of 30 seconds were used per tube with replacement of the sample back 
onto ice during settling.  Samples were sonicated until homogenous.  Following 
sonication, the tubes were placed in the Legend 17R Sorvall
®
 (Thermo Scientific, 
Asheville, NC) tabletop centrifuge and spun for 8 minutes at 4
ᵒ
C and 6000xg.  The 
supernatant of each sample was transferred to a fresh microcentrifuge tube (200uL per 
tube) and the pellet was discarded. 
 
BCA Protein Assay  
A protein assay was performed using the instructions from the Thermo Scientific 
Pierce
®
 BCA Protein Assay Kit (23227; Fisher Scientific, Pittsburgh PA).  Briefly, wash 
reagent was created [5.9mL Reagent A + .118mL Reagent B].  The albumin standard 
(2mg/mL) was diluted according to the test tube procedure and placed in duplicate into a 
96-well plate.  Supernatants were diluted 1:10 [6µL sample + 54µL milli-q H2O] and 
added to the plate in duplicates.  200µL of wash reagent was introduced into each well 
and incubated at 37
ᵒ
C for 20 minutes.  The plate was cooled to room temperature and 
read on a spectrophotometer (Spectramax190, Molecular Devices; Silicon Valley, CA) at 
a wavelength of 562nm.  The results were recorded in SoftMax Pro 5.2 software for data 





The BDNF ELISA was completed using the BDNF Emax
®
 ImmunoAssay System 
(G7611; Promega, Madison WI).  Samples were normalized using Block & Sample 1X 
Buffer [42.4mL of milli-q water + 10.6mL of Block & Sample 5X Buffer] to a 
concentration of 6.75 mg/mL total protein and stored on ice.  Plate coating was carried 
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out the afternoon before running the ELISA.  10uL of anti-BDNF mAb was added to 
9.99mL of carbonate coating buffer [0.025M sodium bicarbonate (AC21712-0010; Acros 
Organics, New Jersey) + 0.025M sodium carbonate (AC20680-0010; Acros Organics); 
adjust pH to 9.7] and mixed thoroughly by inversion.  100µL of this mixture was 
dispensed into each well of a polystyrene ELISA plate (6005600; Perkin Elmer, 
Waltham, Massachusetts) using a multichannel pipettor.  The plate was incubated 
overnight at 4
°
C and the following day the wells were vigorously washed three times with 
tris-buffered saline and tween-20 (TBST) [20mM Tris-HCl (IC816124; VWR) + 150mM 
NaCl (VWR) + 0.05% Tween 20 (H5151; Promega)] using an automated plate washer 
(ELx405 Biotek, Winooski, Vermont).  200µL of Block & Sample 1X Buffer was added 
to each well and the plate was incubated for one hour.  To prepare the standard, the 
supplied BDNF (1 µg/mL) was diluted 1:40 [10µL of undiluted standard + 390µL of 
Block & Sample 1X Buffer], then diluted to 1:2000 [10µL of the first dilution + 490µL 
of Block & Sample 1X Buffer] in a fresh tube and stored at 4ᵒC.  The normalized 
supernatants were acid treated by adding approximately 4µL of 1N HCl to lower the pH 
below 3.0, in order to dephosphorylate and to measure total BDNF protein. The samples 
were incubated for 15 minutes at room temperature, and using 1N NaOH were 
neutralized to a pH of approximately 7.6 and placed back on ice.  Following plate 
blocking, the wells were washed one time vigorously with TBST.    A serial dilution of 
the standard was performed from a concentration of 125pg/mL to 1.95pg/mL, including a 
blank, and samples were added to the plate in duplicate using 100µL of sample per well.  
The plate was sealed using a coverslip and incubated for 2 hours with shaking at room 
temperature.  After incubation, the plate was vigorously washed with TBST.  BDNF 
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primary antibody (pAb; 1:50) was prepared and mixed [9.98mL of Block & Sample 1X 
Buffer + 20µL Anti-Human BDNF pAb] and 100µL of the solution was added to each 
well.  The plate was sealed as before and incubated for an additional 2 hours with 
shaking.  After incubation, the plate was vigorously washed with TBST.  100µL of 
Horseradish Peroxidase (HRP) Conjugate [9.95mL of Block & Sample 1X Buffer + 50µL 
of Anti-IgY HRP conjugate] was added to each well, followed by another 1-hour long 
incubation with shaking and a repeated washing.  100µL of room temperature 3,3,5,5-
tetramethylbenzidine (TMB) One solution (Promega) was added to each well and the 
plate was covered and shaken for 10 minutes.  The wells were a blue tint following this 
incubation.  100µL of 1N HCL was placed into each well, which turned the solutions to a 
yellow tint, and the plate was immediately read on the spectrophotometer at a wavelength 
of 450nM.  Data was collected for analysis using the SoftMax Pro 5.2 software. 
 
Statistical Analysis 
All measurements were analyzed with Statistical Analysis Software (SAS) and 
expressed as mean ± SEM.  If group (Sham, ST-TBI, and EE-TBI) was the only factor, a 
one-way analysis of variance (ANOVA) was performed.  If day was included as a factor, 
as done for the MWM data, a mixed design ANOVA was performed.  Post-hoc paired 
comparisons among the groups used the Tukey procedure with a 0.05 experimentwise 
error level.  For completeness, two-tailed two-sample t-tests were also performed.  If the 









One animal from the sham control group was removed from all statistical 
analysis.  It was determined during sacrifice that the animal suffered a large hematoma 
which resulted in various behavioral, cognitive and biochemical abnormalities.  The sham 
group contained n=13 for MWM, n=6 for the ELISA and n=7 for in-situ statistical 
analysis after removing that animal.   
MWM 
Analysis of the Morris Water Maze data revealed significant differences during 
the second week of testing among groups and days (Figure 9).  Latency to the platform 
(seconds) was used as the dependent variable in a mixed-design ANOVA with both 
group and day serving as the factors. 
 
Figure 9: Morris Water Maze Trends (Mean latency to find platform ± SEM).  During 
the last 4 days of testing (Days 18-21 Post-Injury), the EE-TBI group was able to perform 
as well as the sham controls while the standard housed animals did not, suggesting that 
EE is able to build resistance prior to injury 
 
F-tests showed a significant difference among the ST-TBI, EE-TBI and Sham groups 
(F2,41 = 4.56, p = 0.0162) as well as among the days (F3,121 = 4.20, p = 0.0073) but there 
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by way of the Tukey method showed that ST-TBI was significantly different than both 
Sham and EE-TBI.  Table 1 exhibits pair-wise differences between groups at each day. 
 Latency to Platform (sec) Two-Tailed 
 Level 1 Level 2 Mean Two-Sample t-test 
Day Group Mean SEM Group Mean SEM Diff DF t P 
8 
Sham 20.2 6.4 ST-TBI 40.9 9.1 -20.8 25.0 -1.78 0.0873 
Sham 20.2 6.4 EE-TBI 26.0 5.2 -5.8 26.0 -0.71 0.4822 
ST-TBI 40.9 9.1 EE-TBI 26.0 5.2 14.9 29.0 1.45 0.1582 
9 
Sham 15.9 4.2 ST-TBI 35.7 8.8 -19.7 19.9 -2.03 0.0561 
Sham 15.9 4.2 EE-TBI 12.2 2.5 3.7 26.0 0.79 0.4383 
ST-TBI 35.7 8.8 EE-TBI 12.2 2.5    23.5 16.2 2.57 0.0203 
10 
Sham 13.8 2.6 ST-TBI 32.5 9.7 -18.8 16.1 -1.87 0.0792 
Sham 13.8 2.6 EE-TBI 12.6 2.3 1.2 27.0 0.35 0.7325 
ST-TBI 32.5 9.7 EE-TBI 12.6 2.3 20.0 15.6 2.01 0.0619 
11 
Sham 14.2 2.6 ST-TBI 28.7 9.2 -14.5 16.2 -1.52 0.1477 
Sham 14.2 2.6 EE-TBI 11.2 1.9 3.0 27.0 0.95 0.3513 
ST-TBI 28.7 9.2 EE-TBI 11.2 1.9 17.5 15.2 1.86 0.0817 
Table 1: Results of Two-Tailed Two-Sampled t-test for the MWM 
 
Figure 10 displays the trends of the second week of testing, excluding the last day which 
was used as a probe.  There were no significant differences between the standard housed 
sham and the enriched conditions, but the ST-TBI group took significantly longer to 
reach the platform.   
 



































BDNF and trkB mRNA levels were used as the dependent variable in a one-way 
ANOVA.  The factor was group and levels used were Sham, ST-TBI and EE-TBI.  
Results of the f-tests are shown in Table 3. 
  F-test of Group 
 Location DF F p 
BDNF 
Prefrontal Cingulate 2,18 0.01 0.9966 
Piriform Cortex 2,18 0.18 0.8377 
DG of Hippocampus 2,18 0.99 0.3921 
CA3 of Hippocampus 2,17 0.68 0.5215 
trkB 
Prefrontal Cingulate 2,13 0.13 0.8810 
Piriform Cortex 2,13 0.06 0.9460 
DG of Hippocampus 2,13 7.54 0.0067 
CA3 of Hippocampus 2,13 1.42 0.2769 
Table 2: Results of in-situ hybridization f-test for Sham, ST-TBI and EE-TBI Groups.  No 
significant differences were found in the various brain regions except for trkB in the DG 
(p=0.0067)  
 
Analysis of the film autoradiograms revealed that there were no statistically significant 
differences in BDNF mRNA in any of the measured brain regions among the groups; 
however, in the Dentate Gyrus (DG) there was a significant difference found (F2,13=7.54, 
p=0.0067) for trkB mRNA.  The Tukey procedure revealed Sham was significantly 
different than ST-TBI.  Using the corrected grey scale values from the densitometric 
measurements, it was determined that neither housing conditions nor injury alter the 
levels of BDNF (Figures 11a/11b and 12a/12b/12c) mRNA when observed 33 days post-




Figure 11: BDNF mRNA levels: (a) BDNF mRNA in Prefrontal Cingulate, (b) BDNF 





Figure 12: BDNF mRNA Analysis: (a) BDNF mRNA Levels in Hippocampus Dentate 
Gyrus, (b) BDNF mRNA in CA3 , and (c) autoradiogram image of in situ showing the 
hippocampus   
 
Throughout the various modules of the brain which were observed, the aforementioned 
tests revealed that trkB mRNA levels (Figures 13a/13b and 14a/14b/14c) did not exhibit a 
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Figure 14: trkB mRNA Analysis: (a)  trkB mRNA Levels in Hippocampus Dentate Gyrus, 
(b) BDNF mRNA in CA3, and (c) autoradiogram image of in situ showing the 
hippocampus  
 
Here, it was observed that there was a noteworthy distinction between the Sham and ST-
TBI group; however, the Tukey procedure did not show significant differences between 
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ST-TBI verses EE-TBI for trkB in the DG reveals a low p-value (p=0.0357). Thus, more 
analysis is required to verify this distinction and significance. 
ELISA  
The differences in the quantity of BDNF in the hippocampus among the varying 
conditions were minimal.  BDNF protein concentration (pg/mL) was used as the 
dependent variable in a one-way ANOVA with the group being the factor and did not 
show a significant difference among the EE-TBI, ST-TBI, and Sham groups (F2,17=0.36, 
p=0.6995).  Table 2 contains paired testing among the groups 
 Corrected BDNF Protein Concentration (pg/mL) Two-Tailed 
Level 1 Level 2 Mean Two-Sample t-test 
Group Mean SEM Group Mean SEM Diff DF t p 
Sham 10.9 1.8 ST-TBI 12.9 1.9 -1.9 10.0 -0.74 0.4774 
Sham 10.9 1.8 EE-TBI 11.0 1.6  0.0 12.0 -0.02 0.9841 
ST-TBI 12.9 1.9 EE-TBI 11.0 1.6 1.9 12.0 0.75 0.4664 
Table 3: Results of Two-Tailed Two-Sample t-test for BDNF ELISA 
   
Figure 15 illustrates the trends between the conditions and verifies that changes in BDNF 
protein concentrations among the groups were negligible.  
 





































Environmental enrichment and BDNF can provide cognitive enhancements post-
injury, but little is known about the mechanism of these neuroprotective effects when 
applied prior to injury.  The current research sought to establish a foundational 
understanding of pre-injury EE effects on post-TBI cognitive performance.  In this paper, 
it was hypothesized that EE, when applied prior to injury, would provide protection 
against TBI and that this protection would be accompanied by elevated BDNF mRNA 
and protein levels.  Results determined that EE attenuated cognitive deficits when applied 
prior to injury and that the beneficial effect of EE on cognitive performance was present 
even without detectable changes in BDNF mRNA or protein.  The following discussion 
compares results from the current study to the existing body of knowledge on 
neuroprotective mechanisms, particularly those involving EE and protective 
biomolecules like BDNF.  Identifying techniques which can confer resilience to the brain 
before injury and support neuronal survival could provide the framework for a new area 
of study in neuroprotection.  
Environmental Enrichment Improves Cognitive Performance when Applied Before TBI 
EE applied prior to injury improved spatial memory in rodents compared to 
standard housed animals.  From our research, results for MWM testing of spatial memory 
revealed that during the second week of testing (days 18-21 post-surgery), the effect of 
TBI on decreasing cognitive performance was completely prevented in animals which 
had been exposed to EE (Figure 9).  These results are consistent with studies observing 
the effects of TBI on performance as well as research exploring the effects of enrichment 
when applied after injury
4,27,49,50
.  In particular, Sozda et al. (2010) determined that 
advances in performance on the MWM following TBI and EE introduction may have 
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been caused by attenuation of CA3 hippocampal cell loss as well as a decrease in overall 
lesion volume
28
.  Hamm et al. (1996) and de Witt et al. (2010) found that EE applied after 
injury significantly improved spatial memory performance on the MWM compared to 
injured animals in standard housing which did not receive EE.  Passineau et al. (2001) 
also observed morphological changes near the site of injury and determined that 
enrichment played a role in cell proliferation, growth factor expression and cellular 
metabolism; however, the exact mechanism behind these neuroprotective effects was not 
established
29
.  These studies reiterate the original findings by Rosenzweig et al. (1996) 
which determined that EE has the ability to induce neurochemical, neuroanatomical and 
behavioral alterations
20,30
.  Combined, all the findings show that EE before and after 
injury may improve cognitive performance as indicated by the results in the MWM.  Our 
study, however, was the first to establish data which provided evidence of these 
neuroprotective effects prior to TBI.  
Because decreases in cognitive performance were prevented in the current 
research, additional insight may be gained on which parts of the brain are affected by EE, 
such as the hippocampus.  The hippocampus is important in research involving TBI as 
this structure is especially vulnerable to TBI and is associated to cognitive and behavioral 
dysfunctions, which may include impairments in learning and memory
49,50
.  Yu et al. 
(2009) discovered that rodents displayed significant memory recall impairments in the 
MWM following a CCI injury.  The deficits were more prominent when the injury was 
severe enough to cause damage to the hippocampus, re-establishing the importance of 
this structure in learning and memory
4,27,49,50
.  In our research, EE-TBI animals had no 
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memory deficits compared to ST-TBI, suggesting EE builds resilience when applied prior 
to injury to areas beyond the site of injury, such as the hippocampus.   
TBI Stages Induce Various BDNF Responses 
In addition to the effect EE has on cognitive performance, enrichment has 
elevated BDNF levels
45
.  Combined, EE and elevated BDNF levels could provide 
compounded neuroprotective effects towards the mechanisms following injury.  
Understanding the timing of the stages following a traumatic insult is vital in considering 
techniques to improve function and recovery.  There are three distinct stages of TBI 
response and recovery that induce a variety of biochemical changes in the CNS (Figure 1) 
8,9,52,53
.  In the current study, observation of BDNF levels were limited to the chronic 
stage, in order to obtain behavioral data, but were not found to be significantly different 
between groups.  A more in-depth look at previous findings of BDNF levels during these 
stages may help to explain the current results. 
Acute Stage 
During the acute stage of injury, BDNF levels are shown to be prominently 
elevated following a short delay.  Yang et al. (1996) observed BDNF mRNA and protein 
level elevations occurred one hour following TBI in the hippocampus, but no changes 
were observed in BDNF levels prior to this time point
55
.  The largest increases in these 
levels occurred in the granule cells of the DG followed by the CA3 region of the 
hippocampus.  In the DG, increased mRNA levels for the BDNF receptor, trkB, were also 
observed
27
.  This suggests that a delay in BDNF elevation may be caused by the 
biochemical processes following a TBI.  These processes include elevations in Ca
2+
 
levels as well as neuronal excitation
 
which could activate signaling pathways, such as 
cAMP response element-binding (CREB)
56
.  Additional research completed by Hicks et al. 
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(1997) and Oyesiku and colleagues (1999) reported animals exposed to a TBI 
experienced large increases in BDNF mRNA and protein levels which peaked at 3-12 
hours post-injury.  These elevations in BDNF levels may be eliciting neuroprotective 
effects throughout the brain in an attempt to counteract the effects of the mechanism of 
TBI.   
  The effects seen during the acute phase of injury cannot be counteracted by EE 
unless the enrichment is applied prior to injury.  Currently, no published studies have 
shown the effects of EE during the acute stage of TBI when it is applied post-injury.  This 
is because there is a latency for the neuroprotective effects of EE, so when applied post-
injury the ‘window of opportunity’ to disrupt the cascade of detrimental effects caused by 
a TBI during the acute phase is missed.  The current study shows that when EE is applied 
prior to TBI, changes in cognition are relevant weeks after the injury using the MWM.  
Although these changes were observed during the chronic stage of TBI, disruption of the 
cascade of events during the acute phase by the neuroprotection enforced by EE, and 
possible increases in BDNF, may have played a role in these enhancements.  Increases in 
BDNF during this stage, may have improved performance on certain tasks as displayed 
by BDNF knock-out (KO) mice.  Bramham et al. (2005) found these rodents to have 
severe deficits in MWM tasks attributed to the lack of BDNF, reiterating the role BDNF 
plays in learning and memory
37
. Although these KO mice studies did not investigate 
behavioral changes related to TBI, one can surmise that elevated levels of BDNF protects 
against the detrimental effects of TBI by restoring LTP capabilities and improving 
executive function.   To confirm these ideas, future studies will focus on the effects of 





 During the sub-acute stage of TBI, hours to days following injury, BDNF mRNA 
and protein levels begin to decline.  Research performed by Oyesiku and colleagues 
(1999) determined BDNF was prominently elevated during the acute phase of TBI and 
significant BDNF levels were still observed at 24 hours post-injury, but by 36 hours had 
returned to near control levels
43
.  Hicks et al (1997) found similar results with decreasing 
BDNF and trkB levels starting at 24 hours post-injury which returned to control levels at 
72 hours
48
.  A study completed by Griesbach et al. (2002) observed the trends following a 
TBI and established that BDNF mRNA was still elevated at 24 hours post-injury 
compared to control subjects. These levels were not as significant as those observed 
during the acute phase
54
.  The findings above provide evidence that BDNF levels begin to 
decline during the sub-acute stage which may have accounted for the results of the 
current research, occurring in the chronic stage.        
 Environmental enrichment has been shown to enhance BDNF protein levels and 
neurogenesis in the adult rat brain, especially during the sub-acute stage of TBI
25,45,46
.  It 
is determined that when EE is applied directly following injury, neurogenesis is increased 
which may occur by disrupting some of the effects in these stages such as influencing the  
inflammation process by decreasing the amount of pro-inflammatory cytokines
45,46
.  By 
using enrichment to enhance the amount of BDNF during the sub-acute phase, exposure 
of this neuroprotective component to the hippocampus and area of injury may produce 
cellular enhancements such as dendritic branching, cell proliferation, reduced 
inflammation and enhanced resilience to injury
27,54,57-60
.  Recall in this stage that cytokine 
production normally increases which can lead to inflammation.  Both BDNF and EE have 
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been shown to decrease inflammation which may interrupt the mechanism of TBI and 
account for results in this study by inducing cellular processes which could affect the 
executive function of the subject.  .           
Chronic Stage 
 The current research, performed during the chronic stage, revealed no changes in 
BDNF mRNA and protein levels and only one significant difference was found in the 
trkB levels.  These results are supported by previous research observing the trends of 
BDNF during this stage.  Gobbo et al. (2005) found no significant differences in BDNF 
levels between enriched and standard housed injured animals at 3 weeks post-injury; 
however, BDNF levels were elevated in comparison to the standard housed animals
60
.  In 
a similar study by Bindu et al. (2007) the effects on BDNF levels 3 weeks post-injury 
showed that animals enriched after TBI experienced enhanced dendritic morphology and 
spine density, but the levels of BDNF remained insignificant between housing 
conditions
63
.  Both of these studies demonstrate the positive effect EE may have on 
neuroprotection by elevating BDNF (although not significantly) and enhancing neuronal 
morphology especially when applied after injury.   
The chronic stage was the only stage observed in the current study, and the 
existing results of our research parallel some of the findings above.  In the current study, 
EE exposure prior to a TBI did not significantly elevate BDNF mRNA and protein levels 
in the cortex or hippocampus when observed 33-days following the injury using the 
ELISA and in-situ hybridization quantification techniques.  One finding was that trkB 
levels were reduced significantly in the DG for the ST-TBI group compared to the 
Shams.  Recall during the acute stage of injury, Hicks et al (1999) observed elevated 
levels of trkB in the DG for injured animals.  These levels began to decrease during the 
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sub-acute stage due to cell dystrophy and inflammatory processes, which may have 
resulted in the decreases seen in the current research
48
.  These decreases in trkB receptor 
may have accounted for the deficits seen in the ST-TBI group on the MWM task, a 
measure of learning and memory.  A reduction in receptors will limit BDNF binding sites 
and thus, result in a lack of neuroprotective benefits.  It should be noted that the EE-TBI 
levels were not as diminished as the ST-TBI group, suggesting EE provided some 
neuroprotection against cell death.  There was not a significant difference found between 
the EE-TBI and ST-TBI groups however, and the BDNF levels did not follow the same 
trend as the trkB receptor (Figures 11a and 13a).  This contradiction may be further 
validated by a larger group of samples.  Future investigations using a different stage of 
TBI are required to observe the trends of BDNF, as well as its receptor, in 
neuroprotection.         
TBI Stages Induce Various BDNF Responses  
All of these findings provide supporting evidence that BDNF plays a role 
following a TBI, at least during a particular ‘window of opportunity’.  From the 
referenced studies described above, it can be verified that BDNF has a delayed reaction 
to the impact of injury and that following a certain time-point (~24-72 hours) the levels 
will return to control amounts.  These trends may explain why BDNF levels in our study, 
observed only in the chronic stage, were not significantly different between groups.  
Based on the above data, it is possible our research was past the time point of measuring 
a change in the mRNA and protein intensities.  Future research should include shorter 
time points (possibly 1, 4, 8, 12, 24, 36, or 72 hours) of sacrifice following TBI to obtain 
the mechanism of BDNF in this series of events.             
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The aforementioned studies, as well as the results of our research, illustrate that 
EE helps mitigate the detrimental effects of TBI and that BDNF plays a role in the 
recovery of cognitive function.  The exact mechanism of BDNF in repair and recovery is 
unknown and requires further investigation.  It is accepted that following a TBI, BDNF 
increases until a particular time point to improve cognitive learning and 
neurogenesis
26,27,43,44
.   Enrichment alone can improve cognitive function when applied 
both pre- and post-injury as well as stimulate BDNF production to provide numerous 
neuroprotective advantages
24,25,57,59
.  Without fully understanding the role of BDNF and 
other neuroprotective biomolecules when paired with EE, it is difficult to understand the 
exact mechanism of recovery.                 
 
Hypothesized BDNF Mechanism of Recovery 
Although changes in the levels of BDNF mRNA and protein were not 
distinguishable in this study, BDNF may still have been a factor in neuroprotection.    
Future studies using this enrichment/injury model to observe the BDNF ‘window of 
opportunity’ will provide a more definitive conclusion regarding the recovery 
mechanism.  Until then, a possible mechanism behind this model is hypothesized based 
on the literature and the current results.   
From the current findings and previous research, it is hypothesized that the 
proposed mechanism (Figure 16) is an appropriate model for the trends of BDNF if the 
proper stages are observed.  It should be noted that prior to the induction of injury, BDNF 
levels may have been elevated due to animal exposure to EE.  Recall that EE has been 
shown to enhance BDNF protein levels and neurogenesis in the adult rat brain
25,45,46
.  
From these findings it is also hypothesized that increased BDNF levels, induced by EE 
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prior to the injury, may have caused plasticity in the brain which could result in enhanced 
resilience to injury.  The current study did not allow observation of the levels of BDNF 
prior to injury; however, a study completed by Klein et al. (2011) has shown that there is 
a strong and significant correlation between BDNF levels found in blood plasma and 
BDNF in brain tissue for rats
65
.  Therefore, future studies could observe BDNF trends 
during various key experimental points, including prior to injury, to determine if BDNF 
plays a role in neuroprotection both prior to and following a TBI. 
Figure 16: Possible CREB Influence in TBI and BDNF Mechanism.  A TBI results in HPA axis 
and ATP production dysregulation which activated excess excitatory neurotransmitters as well as 
NMDA receptors.  The excess of neurotransmitters leads to the start of BDNF production, 
activating the MAPK or PI3K pathways.  The PI3K pathway causes the phosphorylation of Akt 
which causes neurogenesis in the brain.  Excitation of the MAPK pathway causes the increased 
production of CREB, which can also be stimulated by the excess calcium produced by the 
activation of the NMDA receptors.  Once CREB is produced, it can fabricate elevated amount of 
BDNF as well as stimulate the BCL2 family to enhance plasticity and neurogenesis in the CNS.    
 
Once the TBI is induced, a cascade of physical and biochemical changes occur in 





.  These catastrophic effects may result in a loss of homeostasis throughout 
the brain which then produces a compensatory response
8
.  There is an excess release of 
excitatory neurotransmitters which then activates the glutamatergic neurons to produce 
BDNF.  BDNF can phosphorylate and bind to its trkB receptor in order to activate 
various signaling pathways, including the PI3K pathways discussed earlier.  Another 
pathway that BDNF can stimulate is the MAPK pathway, which then has the ability to 
phosphorylate transcription factor CREB.  This response is also triggered by an increase 
in Ca
2+
.  The influx in Ca
2+
 can also cause the phosphorylation of CREB
8,9
.  Upon 
activation, CREB regulates neuronal excitation and neurotrophic factor gene transcription 
thus playing a role in neuroprotection
31,64
.  
CREB has anti-apoptotic effects and can reduce cell death in rats introduced to 
EE following an injury
31,64
.  In the hippocampus of these rodents, Walton et al. (2000) 
observed that the neurons resistant to the effects of injury had higher levels of 
phosphorylated CREB
56
.  Once phosphorylated, CREB can induce and increase BDNF 
production, become co-localized with BDNF in the neurons of the hippocampus and has 
the ability to regulate the transcription of BDNF directly through the MAPK and 
PI3K/Akt pathways (Figure 4 & 16)
64,56
.  Walton et al. (2000) demonstrated that Akt can 
be directly phosphorylated by CREB, providing further neuroprotective effects by 
continuing the cascade in the B-cell lymphoma 2 (BCL2) family which promotes cell 
survival and blocks apoptosis (Figure 16)
52,56
.  These changes then increase BDNF 
mRNA and protein levels. 
This intricate series of events aids in understanding the results of the current 
study.  From this cascade, it can be determined that the induction of BDNF production is 
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not immediate, but requires a specific series of events to occur prior to being influenced. 
Yang et al. (1996) reported similar trends and found that BDNF levels were not elevated 
following a TBI until one hour post-injury
55
.   BDNF levels will elevate and fall in a 
time-dependent manner with the highest expression levels occurring once mRNA and 
protein production has been initiated; however, following the acute stage of TBI, levels 
will begin to decrease due to the loss of stimulation both in the PI3K pathway and CREB.  
This decrease in BDNF may take between hours and days due to the extent of damage, 
stimulation and inflammatory influence. 
 Neurotrophins may provide neuroprotective benefits during the sub-acute and 
chronic stages of TBI, specifically in inflammation (not included in Figure 15).  Piehl et 
al. (2001) determined that neurotrophic factor production by the invading immune cells 
may diminish some of the negative effects of inflammation
15,16
.  Kerschensteiner et al. 
(1999) found that immune cells, such as T cells and B cells, possess the ability to produce 
BDNF
52
.  It is therefore also hypothesized that increasing BDNF production during the 
immune response may aid in minimizing neuronal damage through down-regulation of 
other degenerative immune responses
52
.  Inflammatory processes can last from days to 
weeks, but the current study showed no increase in BDNF protein or mRNA levels 
throughout the hippocampus.  This may have been due to a reduced inflammatory 
response in the hippocampus caused by the positive influence EE may have played in 
making the brain more resilient to these neurodegenerative effects.  To determine if this 
theory is accurate, observing alterations in cytokines using multiplexing techniques 
would help to determine the role EE and BDNF have during these stages and processes.    
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By observing trends of numerous biomolecules (BDNF, CREB, BCL2, Akt) in 
this hypothesized model, verification of this model will be elucidated.  These molecules 
should be observed in both the cortex and hippocampus using techniques such as 
microarray, RT-PCR, ELISA or immunohistochemistry.  In addition to observing gene 
expression changes, the phosphorylated proteins can be analyzed via western blot 
techniques to verify activation of the proposed signaling pathways.  By determining 
activation of these biomolecules and expression levels, a more pronounced picture of the 
mechanism of recover following TBI will be elucidated. 
Verifying that this model is correct and determining the influence the BDNF has 
prior to injury as well as throughout the stages of TBI will help to develop new 

























The hypothesis of this research was that BDNF mRNA and protein levels would 
be elevated in animals which were environmentally enriched prior to TBI compared to 
non-enriched animals.  It was revealed that EE attenuated the injury-induced deficits in 
memory when applied prior to injury.  This study also revealed that exposure to EE prior 
to a TBI did not elevate BDNF mRNA and protein levels in the cortex or hippocampus 
when observed 33-days following the injury.  There was however a significant difference 
found among trkB levels in the DG of the hippocampus.  The findings from this study 
were critical in establishing the benefit of neuroprotection that EE provides when applied 
prior to TBI.     
Future research is necessary to focus on the biochemical changes of this repair 
mechanism.  To do so, specific times of sacrifices would be developed in order to 
observe trends in BDNF and trkB during the opportune time, and determine if enriched 
animals show more resilience following an injury as measured by increasing levels of 
BDNF.  Other studies may determine the most effective models of enrichment which will 
result in enhanced resistance and optimal levels of BDNF. 
Determining the underlying neuroprotective mechanisms will have a significant 
impact on developing effective preventative measures to mitigate the debilitating effects 
of TBI.  These techniques will provide valuable understanding of the stages of TBI which 
will allow for the disruption of neurodegenerative processes and improved cognitive 
function.  This research will continue to benefit the 1.7 million people affected yearly by 
this debilitating action and has exceptional potential for aiding the resilience of soldiers 




 mRNA Level Two-Tailed 
 Level 1 Level 2 Mean Two-Sample t-test 




          
Sham 158.5 11.0 ST-TBI 159.6 22.6 -1.1 12.0 -0.04 0.9655 
Sham 158.5 11.0 EE-TBI 160.5 16.2 -2.0 12.0 -0.10 0.9196 




          
Sham 135.4 14.8 ST-TBI 136.7   8.2 -1.3 12.0 -0.08 0.9404 
Sham 135.4 14.8 EE-TBI 127.9   9.5 7.5 12.0 0.43 0.6779 




          
Sham 239.8 23.5 ST-TBI 208.8 21.9 31.0 12.0 0.96 0.3541 
Sham 239.8 23.5 EE-TBI 202.0 14.1 37.7 12.0 1.38 0.1941 




          
Sham 202.0 19.6 ST-TBI 178.5   5.0 23.6   6.8 1.16 0.2839 
Sham 202.0 19.6 EE-TBI 190.1 11.6 12.0 12.0 0.52 0.6098 




          
Sham 292.2 18.0 ST-TBI 310.9 39.1 -18.7   9.0 -0.46 0.6563 
Sham 292.2 18.0 EE-TBI 306.3 25.9 -14.1   9.0 -0.46 0.6568 




          
Sham 147.6 11.4 ST-TBI 152.8 10.8 -5.1   9.0 -0.32 0.7538 
Sham 147.6 11.4 EE-TBI 150.7 11.0 -3.1   9.0 -0.19 0.8523 




          
Sham 193.4 13.4 ST-TBI 134.8   9.0   58.6   9.0 3.74 0.0046 
Sham 193.4 13.4 EE-TBI 168.7 10.5 24.7   8.0 1.45 0.1856 




          
Sham 163.3 16.0 ST-TBI 138.6   6.0 24.7   9.0 1.55 0.1556 
Sham 163.3 16.0 EE-TBI 144.9   9.4 18.3   8.0 0.99 0.3520 
ST-TBI 138.6   6.0 EE-TBI 144.9   9.4 -6.3   9.0 -0.59 0.5704 
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